Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Avalus Ultra Post-Approval Study (PAS)

NCT: NCT06506903 · ACTIVE_NOT_RECRUITING

NCT IDNCT06506903

StatusACTIVE_NOT_RECRUITING

Start Date2024-11-20

Brief Summary

The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑